Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression

被引:25
作者
Chen, Rong-Xin [1 ,2 ,3 ]
Xia, Yun-Hong [1 ,2 ,3 ]
Xue, Tong-Chun [1 ,2 ,3 ]
Ye, Sheng-Long [1 ,2 ,3 ]
机构
[1] Fudan Univ, Liver Canc Inst, Shanghai 200032, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China
[3] Chinese Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai 200032, Peoples R China
关键词
Hepatocellular carcinoma; Invasion; Osteopontin; FACTOR-KAPPA-B; PLASMINOGEN-ACTIVATOR; CANCER PROGRESSION; PROSTATE-CANCER; METASTASIS;
D O I
10.1007/s11033-010-0481-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Osteopontin (OPN) is over-expressed in a variety of cancers, but its role in hepatocellular carcinoma (HCC) progression has not been clarified. In this study, weakly tumorigenic, non-metastastic human HCC cell line SMMC-7721 cells were forced to over-express OPN via stable transfection. A series of functional assays were performed to assess the effects of OPN on tumor cell behaviors and cDNA microarray was used to identify the genes regulated by OPN. The results showed that OPN significantly enhanced the migration and invasion of SMMC-7721 cells in vitro. In addition, CD44v6 antibody could significantly inhibit the invasion of OPN over-expressing SMMC-7721 cells. Moreover, MMP-2 and uPA expressions were significantly up-regulated in OPN over-expressing SMMC-7721 cells. Together, these findings indicate that OPN enhanced HCC cells invasion through interaction with its receptor CD44v6 and increased MMP-2 and uPA expressions, providing at least one mechanism for OPN-mediated HCC progression and metastasis.
引用
收藏
页码:3671 / 3677
页数:7
相关论文
共 19 条
[1]   Activation of the Osteopontin/Matrix Metalloproteinase-9 Pathway Correlates with Prostate Cancer Progression [J].
Castellano, Giancarlo ;
Malaponte, Grazia ;
Mazzarino, Maria C. ;
Figini, Mariangela ;
Marchese, Francesco ;
Gangemi, Pietro ;
Travali, Salvatore ;
Stivala, Franca ;
Canevari, Silvana ;
Libra, Massimo .
CLINICAL CANCER RESEARCH, 2008, 14 (22) :7470-7480
[2]   Evaluation of nuclear factor-κB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma [J].
Chan, CF ;
Yau, TO ;
Jin, DY ;
Wong, CM ;
Fan, ST ;
Ng, IOL .
CLINICAL CANCER RESEARCH, 2004, 10 (12) :4140-4149
[3]   Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies [J].
Coppola, D ;
Szabo, M ;
Boulware, D ;
Muraca, P ;
Alsarraj, M ;
Chambers, AF ;
Yeatman, TJ .
CLINICAL CANCER RESEARCH, 2004, 10 (01) :184-190
[4]   Osteopontin:: it's role in regulation of cell motility and nuclear factor κB-mediated urokinase type plasminogen activator expression [J].
Das, R ;
Philip, S ;
Mahabeleshwar, GH ;
Bulbule, A ;
Kundu, GC .
IUBMB LIFE, 2005, 57 (06) :441-447
[5]   Role of osteopontin in cellular signaling and metastatic phenotype [J].
El-Tanani, Mohamed K. .
FRONTIERS IN BIOSCIENCE, 2008, 13 :4276-4284
[6]   The regulation and role of osteopontin in malignant transformation and cancer [J].
El-Tanani, Mohamed K. ;
Campbell, Frederick Charles ;
Kurisetty, Vittal ;
Jin, Dachuan ;
McCann, Mella ;
Rudland, Philip S. .
CYTOKINE & GROWTH FACTOR REVIEWS, 2006, 17 (06) :463-474
[7]   Osteoprotegrin and the bone homing and colonization potential of breast cancer cells [J].
Kapoor, Preeti ;
Suva, Larry J. ;
Welch, Danny R. ;
Donahue, Henry J. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 103 (01) :30-41
[8]   Increased expression of osteopontin contributes to the progression of prostate cancer [J].
Khodavirdi, AC ;
Song, ZG ;
Yang, SX ;
Zhong, C ;
Wang, SY ;
Wu, H ;
Pritchard, C ;
Nelson, PS ;
Roy-Burman, P .
CANCER RESEARCH, 2006, 66 (02) :883-888
[9]  
Lin HM, 2007, ONCOL REP, V17, P1541
[10]   Hepatocellular carcinoma [J].
Llovet, JM ;
Burroughs, A ;
Bruix, J .
LANCET, 2003, 362 (9399) :1907-1917